AVANT GUARD: Pulsed-field ablation as a first-line treatment for persistent atrial fibrillation
This Medudy course is a video tutorial for physicians on the topic of “Pulsed-field ablation as first-line therapy for persistent atrial fibrillation.” The format used here is a “Journal Club Summary,” in which we summarize the latest and most clinically relevant studies for you. For paroxysmal atrial fibrillation, catheter ablation is already recognized as a first-line therapy; for persistent atrial fibrillation, […]
The Capla 1000+ Project
This Medudy course is a video tutorial for physicians on the topic of “The Capla 1000+ Project.” The format used here is a “Journal Club Summary,” in which we summarize individual studies for you. Caplacizumab is a monoclonal nanobody that inhibits the binding of platelets to von Willebrand factor and has been approved since 2018 for the treatment of […]
HER2 Diagnostics as the Key to Targeted Therapy Decisions
This Medudy course is a video tutorial for physicians on the topic “HER2 Diagnostics as the Key to Targeted Therapy Decisions.” In this video, Professor Markus Eckstein, senior physician at the Institute of Pathology at Erlangen University Hospital, explains the relationship between HER2 diagnostics and the use of targeted therapies for various solid tumors. Essentially, there are three therapeutically relevant alterations […]
63rd ERA Congress 2026 – Key Highlights
This Medudy course is a conference report for physicians on the topic “63rd ERA Congress 2026 – Key Highlights.” Prof. Dr. Jörg Latus, Head of the Department of Internal Medicine and Nephrology at Robert Bosch Hospital in Stuttgart, will summarize key study highlights from the conference for you. The results of the Phase III FIND-CKD study evaluating the efficacy and […] will be presented.
ASCO 2026 – Updates on RCC & MIBC
This Medudy course is a conference report for physicians on the topic “ASCO 2026 – Updates on RCC & MIBC.” Prof. Dr. med. Günter Niegisch, senior physician at the Department of Urology at the University Hospital of Düsseldorf, will summarize key study highlights from the conference for you. The presentation will cover the results of a study on patients’ perception of toxicity following adjuvant ICI therapy and […]
Biliary carcinomas: First-line chemoimmunotherapy and marker-based treatment sequence
This Medudy course is a video tutorial for physicians on the topic of “Biliary carcinomas: First-line chemoimmunotherapy and marker-based treatment sequences.” Prof. Dr. Dirk Arnold, Director of the Asklepios Tumor Center Hamburg and of the Department of Oncology, Hematology, Palliative Medicine, Rheumatology, and Pulmonology at the Asklepios Clinic Altona, provides an overview in this video of the […]
First-line treatment of MSI-H/dMMR metastatic colorectal cancer: IO monotherapy or IO combination therapy—a case-based treatment decision
This Medudy course is a video tutorial for physicians on the topic “First-line therapy for MSI-H/dMMR metastatic colorectal cancer: IO monotherapy or IO combination therapy—a case-based treatment decision.” Prof. Dr. Dirk Arnold, Director of the Asklepios Tumor Center Hamburg and of the Department of Oncology, Hematology, Palliative Medicine, Rheumatology, and Pulmonology at the Asklepios Clinic Altona, explains in this video […]
Environmental toxins and Parkinson's disease
This Medudy course is a video tutorial for physicians on the topic of “Environmental Toxins and Parkinson’s Disease.” The format used here is a “Journal Club Summary,” in which we summarize the latest and most clinically relevant studies for you. Parkinson’s disease is the fastest-growing neurological disorder worldwide—currently affecting around 12 million people. At the same time […]
ASCO 2026 – Updates on Prostate Cancer
This Medudy course is a conference report for physicians on the topic “ASCO 2026 – Updates on Prostate Cancer.” Prof. Dr. Axel S. Merseburger, Director of the Department of Urology at the Lübeck Campus of the University Medical Center Schleswig-Holstein, will summarize key study highlights from the conference. The results of the Phase III PROTEUS study, which evaluated the efficacy and safety […]
ASCO 2026 – Highlights in Urological Oncology for Clinical Practice
This Medudy course is a video podcast for physicians on the topic “ASCO 2026 – Uro-Oncology Highlights for Clinical Practice.” Prof. Dr. Axel Merseburger (University Medical Center Schleswig-Holstein, Lübeck Campus) and Prof. Dr. Christian Gratzke (University Medical Center Freiburg) summarize what they consider to be the most clinically relevant studies from ASCO 2026 on renal cell, urothelial, and prostate cancer. They discuss, among other things, […]